301 related articles for article (PubMed ID: 20817787)
1. Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.
McCarty SK; Saji M; Zhang X; Jarjoura D; Fusco A; Vasko VV; Ringel MD
Endocr Relat Cancer; 2010 Dec; 17(4):989-99. PubMed ID: 20817787
[TBL] [Abstract][Full Text] [Related]
2. BRAF activates and physically interacts with PAK to regulate cell motility.
McCarty SK; Saji M; Zhang X; Knippler CM; Kirschner LS; Fernandez S; Ringel MD
Endocr Relat Cancer; 2014; 21(6):865-77. PubMed ID: 25228413
[TBL] [Abstract][Full Text] [Related]
3. Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migration.
Ma Y; McCarty SK; Kapuriya NP; Brendel VJ; Wang C; Zhang X; Jarjoura D; Saji M; Chen CS; Ringel MD
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1314-22. PubMed ID: 23709653
[TBL] [Abstract][Full Text] [Related]
4. MAPK- and AKT-activated thyroid cancers are sensitive to group I PAK inhibition.
Knippler CM; Saji M; Rajan N; Porter K; La Perle KMD; Ringel MD
Endocr Relat Cancer; 2019 Aug; 26(8):699-712. PubMed ID: 31146260
[TBL] [Abstract][Full Text] [Related]
5. The subcellular localization of type I p21-activated kinases is controlled by the disordered variable region and polybasic sequences.
Sun X; Su VL; Calderwood DA
J Biol Chem; 2019 Sep; 294(39):14319-14332. PubMed ID: 31391252
[TBL] [Abstract][Full Text] [Related]
6. Signaling, Regulation, and Specificity of the Type II p21-activated Kinases.
Ha BH; Morse EM; Turk BE; Boggon TJ
J Biol Chem; 2015 May; 290(21):12975-83. PubMed ID: 25855792
[TBL] [Abstract][Full Text] [Related]
7. Systemic analysis of the expression and prognostic significance of PAKs in breast cancer.
Dang Y; Guo Y; Ma X; Chao X; Wang F; Cai L; Yan Z; Xie L; Guo X
Genomics; 2020 May; 112(3):2433-2444. PubMed ID: 31987914
[TBL] [Abstract][Full Text] [Related]
8. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.
Siu MK; Wong ES; Chan HY; Kong DS; Woo NW; Tam KF; Ngan HY; Chan QK; Chan DC; Chan KY; Cheung AN
Int J Cancer; 2010 Jul; 127(1):21-31. PubMed ID: 19876919
[TBL] [Abstract][Full Text] [Related]
9. PAK signaling in cancer.
Ye DZ; Field J
Cell Logist; 2012 Apr; 2(2):105-116. PubMed ID: 23162742
[TBL] [Abstract][Full Text] [Related]
10. Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells.
Parvathy M; Sreeja S; Kumar R; Pillai MR
BMC Cancer; 2016 May; 16 Suppl 1(Suppl 1):293. PubMed ID: 27229476
[TBL] [Abstract][Full Text] [Related]
11. Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.
Sikorska J; Gaweł D; Domek H; Rudzińska M; Czarnocka B
BMC Cancer; 2019 Jan; 19(1):85. PubMed ID: 30654768
[TBL] [Abstract][Full Text] [Related]
12. p21-Activated Kinases in Thyroid Cancer.
Bautista L; Knippler CM; Ringel MD
Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32609833
[TBL] [Abstract][Full Text] [Related]
13. P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretion.
Goc A; Al-Azayzih A; Abdalla M; Al-Husein B; Kavuri S; Lee J; Moses K; Somanath PR
J Biol Chem; 2013 Feb; 288(5):3025-35. PubMed ID: 23258534
[TBL] [Abstract][Full Text] [Related]
14. Association of p21-activated kinase-1 activity with aggressive tumor behavior and poor prognosis of head and neck cancer.
Park J; Kim JM; Park JK; Huang S; Kwak SY; Ryu KA; Kong G; Park J; Koo BS
Head Neck; 2015 Jul; 37(7):953-63. PubMed ID: 24634274
[TBL] [Abstract][Full Text] [Related]
15. Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways.
Menges CW; Sementino E; Talarchek J; Xu J; Chernoff J; Peterson JR; Testa JR
Mol Cancer Res; 2012 Sep; 10(9):1178-88. PubMed ID: 22798428
[TBL] [Abstract][Full Text] [Related]
16. p21-activated kinases: three more join the Pak.
Jaffer ZM; Chernoff J
Int J Biochem Cell Biol; 2002 Jul; 34(7):713-7. PubMed ID: 11950587
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of PAK1 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer Cells Through the ERK Pathway.
Wang S; Wang SY; Du F; Han Q; Wang EH; Luo EJ; Liu Y
Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):602-610. PubMed ID: 31394555
[TBL] [Abstract][Full Text] [Related]
18. microRNA-7 regulates cell growth, migration and invasion via direct targeting of PAK1 in thyroid cancer.
Yue K; Wang X; Wu Y; Zhou X; He Q; Duan Y
Mol Med Rep; 2016 Sep; 14(3):2127-34. PubMed ID: 27430434
[TBL] [Abstract][Full Text] [Related]
19. PAK1 and PAK2 in cell metabolism regulation.
Kořánová T; Dvořáček L; Grebeňová D; Röselová P; Obr A; Kuželová K
J Cell Biochem; 2022 Feb; 123(2):375-389. PubMed ID: 34750857
[TBL] [Abstract][Full Text] [Related]
20. P21 activated kinase signaling in cancer.
Rane CK; Minden A
Semin Cancer Biol; 2019 Feb; 54():40-49. PubMed ID: 29330094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
